[1]
Seghatchian, J. 2021. A Viewpoint Commentary: Buffalo as a New Model for Long COVID-19 Study and for Recovering the SARS CoV-2 Polyclonal Neutralizing Antibody, Using an Online Affinity Column Adsorption Technology, for Therapeutic Interventional Modality in Humans: A New Multi-Purpose COVID Research Proposal. Journal of Buffalo Science. 10, (Jun. 2021), 50–51. DOI:https://doi.org/10.6000/1927-520X.2021.10.07.